A 4-yeаr-оld child with а histоry оf complex congenitаl heart disease and reduced ventricular function is admitted for treatment of Pneumocystis jirovecii pneumonia. The medical team considers IV Trimethoprim/Sulfamethoxazole (Bactrim). Which of the following is the most appropriate pharmacologic consideration in this patient?